CurrentEndo
Get Weekly

Topic · page 81 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,201–3,240 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. J Clin Endocrinol Metab

    The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022

    Cohort study

  2. Diabetes Obes Metab

    Associations of a proinflammatory diet, habitual salt intake, and the onset of type 2 diabetes: A prospective cohort study from the UK Biobank

    Cohort study

  3. Diabetes Obes Metab

    Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes

    Meta-analysis

  4. Diabetologia

    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study

    Cohort study

  5. Diabetologia

    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people

    Secondary analysis

  6. Lancet Diabetes Endocrinol

    5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study

    Randomized controlled trial

  7. J Diabetes Sci Technol

    Postoperative Length of Stay in Patients With Stress Hyperglycemia Compared to Patients With Diabetic Hyperglycemia: A Retrospective Cohort Study

    Cohort study

  8. Cardiovasc Diabetol

    Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study

    Secondary analysis

  9. Cardiovasc Diabetol

    Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)

    Meta-analysis

  10. Cardiovasc Diabetol

    Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study

    Cohort study

  11. Cardiovasc Diabetol

    Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study

    Cohort study

  12. Diabetes Obes Metab

    Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis

    Meta-analysis

  13. Diabetes Care

    Historic Redlining and Impact of Structural Racism on Diabetes Prevalence in a Nationally Representative Sample of U.S. Adults

    Cross-sectional study

  14. Diabetologia

    Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

    Diagnostic or prognostic study

  15. Diabet Med

    Roles and competencies of the clinical psychologist in adult diabetes care—A consensus report

    Guideline or statement

  16. Diabetologia

    Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study

    Cohort study

  17. Diabetes Obes Metab

    Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study

    Research article

  18. J Clin Endocrinol Metab

    Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement

    Guideline or statement

  19. Diabetes Care

    Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K.

    Mechanistic study

  20. Diabetes Care

    Disparities in Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population—A Retrospective Cohort Study

    Cohort study

  21. Diabetes Obes Metab

    Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents

    Meta-analysis

  22. Diabetes Care

    Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes: Findings From Two Large Prospective Cohorts

    Cohort study

  23. Cardiovasc Diabetol

    The association between the AIP and undiagnosed diabetes in ACS patients with different body mass indexes and LDL-C levels: findings from the CCC-ACS project

    Cross-sectional study

  24. Cardiovasc Diabetol

    Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states

    Cross-sectional study

  25. J Clin Endocrinol Metab

    Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication

    Research article

  26. Diabetologia

    An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study

    Diagnostic or prognostic study

  27. BMJ Open Diabetes Res Care

    Enhanced prediction of abnormal glucose tolerance using an extended non-invasive risk score incorporating routine renal biochemistry

    Diagnostic or prognostic study

  28. Diabetes Care

    Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

    Cohort study

  29. Pediatr Diabetes

    Incidence, Phenotypes, and Genotypes of Neonatal Diabetes: A 16-Year Experience. The Rare Genetic Etiologies of Neonatal Diabetes Are Common in Sudan

    Cohort study

  30. Cardiovasc Diabetol

    The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis

    Meta-analysis

  31. Cardiovasc Diabetol

    Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

    Cohort study

  32. Cardiovasc Diabetol

    Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials

    Meta-analysis

  33. Diabetes Res Clin Pract

    Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults

    Cohort study

  34. Diabetes Obes Metab

    Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data

    Cohort study

  35. J Clin Endocrinol Metab

    Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes

    Cohort study

  36. Diabetes Obes Metab

    Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study

    Cohort study

  37. Diabetes Care

    Plant-Based Dietary Patterns and Incident Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study

    Cohort study

  38. Cardiovasc Diabetol

    Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts

    Cross-sectional study

  39. BMJ

    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study

    Cohort study

  40. J Clin Endocrinol Metab

    Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics

    Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 3,201–3,240 of 4,758, newest first